Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Statistical Modeling in Clinical Research

Background:

• Traditional bioavailability (BA) and bioequivalence (BE) studies rely on summarized pharmacokinetic (PK) parameters like AUC and C(max).
• These summarized parameters can lead to information loss and inaccurate inferences due to the nature of repeated concentration measurements.

Purpose of the Study:

• To develop a novel statistical method for directly comparing drug concentration-time curves.
• To improve the accuracy of pharmacokinetic analyses in BA/BE studies by utilizing all repeated measurements.

Main Methods:

• A functional linear model is proposed to analyze concentration curves directly, rather than relying on derived PK parameters.
• A multiple testing procedure is developed to rigorously assess the equality of two concentration curves, accounting for repeated measures.

Main Results:

• The functional linear model allows for a more comprehensive analysis of concentration-time data.
• The proposed multiple testing procedure provides a robust method for curve comparison in BA/BE studies.

Conclusions:

• The developed functional linear model and multiple testing procedure offer a more accurate and informative approach to pharmacokinetic analysis.
• This method enhances the assessment of bioavailability and bioequivalence by directly comparing concentration curves.